NCT07465458 2026-03-16
RASROP-003
Humanitas Hospital, Italy
Not yet recruiting
Clinical Trials
7 trialsNCT02264548 2023-03-09
A Phase I Evaluating Integration of HypofractionatedStudy Renal Ablative Radiotherapy
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase 1 Completed
NCT02138578 2017-11-07
Trial Comparing Stereotactic Body Radiation Therapy to Radiofrequency Ablation for Renal Cell Carcinoma
University of Michigan Rogel Cancer Center
Phase NA Terminated
NCT00019955 2015-04-29
Radiofrequency Interstitial Tissue Ablation in Treating Patients With Localized Renal Cell Carcinoma (Kidney Cancer)
National Cancer Institute (NCI)
Phase 2 Completed
NCT00891475 2014-02-13
Palliative Radiofrequency Ablation in Metastatic Renal Cell Carcinoma Patients
Kidney Cancer Research Bureau
Phase 1/2 Completed
NCT00601120 2013-02-27
RF Ablation of Treatment of Metastatic Lesions in Patients Undergoing Antiangiogenic Therapy for Stage IV Renal Cell Carcinoma
Dana-Farber Cancer Institute
Phase NA Withdrawn
NCT00006255 2010-06-11
Magnetic Resonance Imaging-guided Thermal Radiofrequencey Ablation of Primary Renal Cell Carcinoma, Hepatic Metastasis, and Other Sites of Solid Organ Tumor and Metastases
Case Comprehensive Cancer Center
Phase 2 Completed